Table 1.
COVID-19 patients | Control patients | P | |
---|---|---|---|
N (%)/N ± SD | N (%)/N ± SD | ||
Age | 30.97 ± 4.13 | 29.97 ± 3.43 | 0.0871 |
Parity | |||
1 | 40 (66.67) | 80 (66.67) | – |
2 | 19 (31.67) | 38 (31.67) | |
3 | 1 (1.67) | 2 (1.67) | |
Fetus number | |||
1 | 59 (98.33) | 118 (98.33) | – |
2 | 1 (1.67) | 2 (1.67) | |
Chronic disease | |||
None | 36 (60.00) | 72 (60.00) | – |
Diabetes | 10 (16.67) | 20 (16.67) | |
Hypertension | 8 (13.33) | 16 (13.34) | |
Diabetes and hypertension | 3 (5.00) | 6 (5.00) | |
Hypothyroidism | 2 (3.33) | 4 (3.33) | |
Hepatic disease | 1 (1.67) | 2 (1.67) | |
Gestational week of delivery | 37.87 ± 2.36 | 38.81 ± 1.81 | 0.0078 |
Gestational week of delivery | |||
<37 | 10 (16.67) | 9 (7.50) | 0.0599 |
≥37 | 50 (83.33) | 111 (92.50) | |
Delivery | |||
Vaginal delivery | 17 (28.33) | 69 (57.50) | 0.0002 |
Cesarean delivery | 43 (71.67) | 51 (42.50) | |
First symptoms | |||
None | 26 (28.33) | 0 | – |
Fever before or during delivery | 11 (18.33) | 0 | |
Fever after delivery | 23 (38.33) | 0 | |
Respiratory symptoms | 9 (15.00) | 0 | |
Neonatal birthweight (g) | 3220 ± 622 | 3251 ± 520 | 0.7247 |
1-min Apgar scores | |||
10 | 38 (63.33) | 14 (58.33) | 0.5152 |
<10 | 22 (36.67) | 10 (41.67) | |
5-min Apgar scores | |||
10 | 57 (95.00) | 23 (95.83) | 0.8105 |
<10 | 3 (5.00) | 1 (4.17) |